Table 1.
N (%) | |
---|---|
Age at survey, yearsa | 32.7 (5.7) |
Race | |
White | 188 (79.3) |
Black | 9 (3.8) |
Asian | 13 (5.5) |
Other | 27 (11.4) |
Ethnicity | |
Hispanic/Latino | 20 (8.4) |
Not Hispanic/Latino | 217 (91.6) |
Relationship status | |
Partnered | 135 (57.0) |
Not Partnered | 102 (43.0) |
Education | |
College graduate | 200 (84.4) |
Did not graduate from college | 37 (15.6) |
Income | |
≤$50,000 | 74 (31.2) |
>$50,000 | 117 (49.4) |
Decline to answer | 46 (19.4) |
BMIa | 25.9 (6.9) |
Has biological child(ren) | 67 (28.2) |
Desires child(ren) | 171 (71.9) |
Cancer characteristics and treatment | |
Cancer type | |
Breast | 66 (27.9) |
Lymphoma | 62 (26.1) |
Gynecologic (cervix/uterus/ovary) | 19 (8.0) |
Blood/leukemia | 19 (8.0) |
Thyroid | 14 (5.9) |
Other | 57 (24.1) |
Cancer stage | |
High Risk | 3 (1.3) |
Standard Risk | 2 (0.8) |
Low Risk | 1 (0.4) |
I | 48 (20.3) |
II | 74 (31.2) |
III | 40 (16.9) |
IV | 18 (7.6) |
Unknown | 51 (21.5) |
Age at diagnosis, yearsa | 27.1 (7.1) |
< 15 | 12 (5.0) |
15–39 | 223 (93.7) |
40–44 | 3 (1.3) |
Time since diagnosis, yearsa | 5.5 (4.7) |
Surgery | 145 (61.2) |
Chemotherapy | 187 (78.9) |
Radiation | 117 (49.4) |
Endocrine therapy | 43 (18.1) |
Bone marrow or stem cell transplant | 14 (5.9) |
Unknown | 1 (0.4) |
Note. Due to missing data, some variables do not add up to 238.
Mean (Standard Deviation)